GlaxoSmithKline completes sale of Aspen shares, raising $694 million [ BeritaTerkini ]

<div id="yom-ad-LREC" class="yom-ad yom-ad-LREC"> <center> <div id="yom-ad-LREC-iframe" class="yom-ad"></div> </center> </div> <p><br></p> <div class="body-slot-container"> <div class="body-slot-mod"> <div class="yom-remote"> <div class="yom-loading" id="mediacontentrelatedstory_container"></div> </div> </div> </div> <p>LONDON (Reuters) – GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen Pharmacare at 250 rand each, raising gross proceeds of 7.059 billion rand ($ 694 million).</p> <p>Shares in the South African drug maker closed at 267.40 rand on Tuesday.</p> <p>GSK had previously said it planned to reduce its investment in the South African drug maker by one third, while remaining committed to working closely with Aspen. It now has a reduced stake of 12.4 percent.</p> <p>($ 1 = 10.1738 South African rand)</p> <p>(Reporting by Ben Hirschler)</p> <ul id="topics" class="hidden"> <li>Investment & Company Information</li> <li>GlaxoSmithKline</li> </ul><p></p> //<!--[CDATA[ jQuery(".gmframe").load(function (){jQuery(this).remove();}); //]]--> <br><br>

GlaxoSmithKline completes sale of Aspen shares, raising $694 million [ BeritaTerkini ]

LONDON (Reuters) – GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen Pha...

Read more »